Poor Sleep and Insomnia

What this symptom feels like

People experiencing poor sleep or insomnia describe a range of frustrating patterns: lying awake for 30 minutes or more trying to fall asleep, waking multiple times during the night and struggling to return to sleep, waking far earlier than desired, or sleeping through the night but waking feeling exhausted and unrefreshed. Daytime consequences include fatigue, difficulty concentrating, irritability, increased errors at work, and sometimes overwhelming sleepiness that interferes with driving or daily tasks.

Acute insomnia lasting days to a few weeks is common during stressful life events and typically resolves on its own. Chronic insomnia—poor sleep occurring at least three nights per week for three months or longer—often reflects one or more underlying medical, psychiatric, or lifestyle contributors and warrants thorough evaluation.

Common evidence-supported contributors

Poor sleep is rarely the result of a single cause. Clinicians assess multiple overlapping categories:

• Sleep disorders: Obstructive sleep apnea (repeated upper airway collapse during sleep), restless legs syndrome, periodic limb movement disorder, and circadian rhythm disorders (shift work, jet lag, delayed sleep phase) are common structural and neurologic causes of fragmented or non-restorative sleep.
• Endocrine and hormonal: Hypothyroidism and hyperthyroidism both disrupt sleep architecture. Perimenopausal and menopausal estrogen and progesterone fluctuations contribute to night sweats and insomnia. Low testosterone in men and women has been associated with poor sleep quality in observational studies.
• Mental health: Anxiety disorders and major depressive disorder frequently present with or cause insomnia. Conversely, chronic sleep deprivation worsens mood and anxiety, creating a bidirectional relationship.
• Pain and medical conditions: Chronic pain from arthritis, neuropathy, fibromyalgia, or injury disrupts sleep continuity. Gastroesophageal reflux, nocturia (frequent nighttime urination), chronic obstructive pulmonary disease, and heart failure all fragment sleep.
• Medications and substances: Stimulants (caffeine, nicotine, amphetamines), alcohol (which fragments sleep in the second half of the night), beta-blockers, corticosteroids, and some antidepressants can impair sleep quality. Benzodiazepine and sleep medication dependence can paradoxically worsen insomnia over time.
• Sleep hygiene and behavior: Irregular sleep schedules, evening light exposure (especially blue light from screens), lack of daytime physical activity, excessive daytime napping, and a sleep environment that is too warm, bright, or noisy all reduce sleep quality.
• Nutritional and metabolic: Iron deficiency (especially in restless legs syndrome), vitamin D deficiency, and blood sugar dysregulation have been linked to poor sleep in multiple studies.

When to see a licensed medical provider

Any adult with poor sleep lasting more than a few weeks should discuss the symptom with a licensed provider. Certain red flags require prompt—sometimes urgent—evaluation:

• Witnessed apneas or gasping: A bed partner observing you stop breathing or gasp for air during sleep is a hallmark sign of obstructive sleep apnea, which increases risk of hypertension, stroke, and sudden cardiac death.
• Severe daytime sleepiness: Falling asleep unintentionally during conversation, meals, or while driving suggests dangerous sleep deprivation or a primary sleep disorder such as narcolepsy or severe sleep apnea.
• Morning headaches: Frequent headaches upon waking, especially with snoring and witnessed apneas, suggest nocturnal hypoxia from sleep apnea.
• Hallucinations or sleep paralysis: Vivid hallucinations when falling asleep or waking, or the sensation of being awake but unable to move, may indicate narcolepsy or another primary sleep disorder.
• New or worsening mood changes: Suicidal thoughts, severe anxiety, or rapid mood changes accompanying insomnia require immediate mental health evaluation.

Even in the absence of red flags, chronic insomnia warrants evaluation because untreated poor sleep independently increases risk for cardiovascular disease, metabolic syndrome, cognitive decline, and all-cause mortality.

What a medical workup typically includes

A comprehensive sleep evaluation begins with a detailed history: sleep and wake times, time to fall asleep, number and duration of awakenings, daytime naps, caffeine and alcohol intake, medication and supplement list, snoring or witnessed apneas, mood symptoms, pain, and occupational or lifestyle stressors. Many providers use validated questionnaires such as the Insomnia Severity Index, Epworth Sleepiness Scale, or STOP-BANG (a sleep apnea screening tool).

Laboratory evaluation often includes thyroid-stimulating hormone (TSH) and free T4 to screen for thyroid disorders, complete blood count and ferritin to assess for anemia and iron deficiency, comprehensive metabolic panel to evaluate kidney and liver function and electrolytes, and sometimes vitamin D and hemoglobin A1c. In men and women with symptoms of androgen deficiency, morning total and free testosterone may be measured. In perimenopausal or menopausal women, estradiol and follicle-stimulating hormone may be assessed, though treatment decisions are typically based on symptoms rather than lab values alone.

Sleep study referral (polysomnography or home sleep apnea testing) is indicated when the history suggests sleep apnea, periodic limb movements, or another primary sleep disorder. Polysomnography records brain waves, oxygen levels, heart rate, breathing, and limb movements during sleep and is the gold standard for diagnosing most sleep disorders.

Mental health screening using tools such as the Patient Health Questionnaire-9 (PHQ-9) for depression and Generalized Anxiety Disorder-7 (GAD-7) for anxiety helps identify psychiatric contributors. Referral to a mental health professional or sleep psychologist for cognitive-behavioral therapy for insomnia (CBT-I) is often recommended; CBT-I has strong evidence as a first-line treatment for chronic insomnia and produces durable improvements without medication.

In some cases, providers may recommend a sleep diary (tracking sleep and wake times for one to two weeks) or actigraphy (a wrist-worn device that objectively measures sleep-wake patterns).

How peptide therapy education fits in

Several peptides are being studied for their potential roles in sleep regulation, circadian rhythm support, and neuroendocrine function related to sleep quality. It is essential to understand that these therapies are investigational for sleep disturbances, are not FDA-approved for insomnia or poor sleep, and require comprehensive provider evaluation and ongoing monitoring.

DSIP (Delta Sleep-Inducing Peptide) has been studied in small trials for its potential to modulate sleep architecture, though robust clinical evidence for efficacy and safety in chronic insomnia is limited. Epithalon is being investigated for circadian rhythm regulation and pineal gland function. Growth hormone-releasing peptides such as ipamorelin and CJC-1295 have been studied in the context of growth hormone optimization; because growth hormone is secreted primarily during deep sleep, some researchers have explored whether optimizing growth hormone pulsatility might improve sleep quality, but this remains investigational.

Importantly, not every person with poor sleep is a candidate for peptide therapy. Sleep apnea, thyroid disease, major depression, medication side effects, and poor sleep hygiene must be identified and addressed first. Peptide therapy, when considered, is one component of a comprehensive, individualized plan directed by a licensed provider. Compounded peptides are not FDA-approved, and their use requires informed consent, monitoring, and adherence to state and federal regulations.

Any suggestion that a peptide "treats" or "cures" insomnia is inaccurate. The evidence base for peptides in sleep medicine is preliminary, and their role—if any—is adjunctive and requires rigorous provider oversight.

What you can discuss with your provider

Bringing organized information to your appointment helps your provider perform a thorough evaluation. Consider discussing:

• Your typical bedtime, wake time, and total sleep duration on weekdays and weekends; how long it takes you to fall asleep; and how many times you wake during the night.
• Whether a bed partner has noticed snoring, gasping, or pauses in breathing during your sleep.
• Daytime sleepiness: do you fall asleep unintentionally, struggle to stay awake during routine tasks, or feel unrefreshed despite adequate time in bed?
• Mood symptoms: feelings of sadness, hopelessness, excessive worry, or loss of interest in activities you once enjoyed.
• Medications, supplements, caffeine, nicotine, and alcohol use.
• Evening routines: screen time, exercise timing, meal timing, bedroom environment (temperature, light, noise).
• Whether you have chronic pain, frequent nighttime urination, heartburn, or other physical symptoms that wake you.
• Your interest in evidence-based interventions such as cognitive-behavioral therapy for insomnia, sleep hygiene optimization, or—after ruling out reversible causes—investigational therapies including peptides.

Ask your provider whether a sleep study, thyroid or metabolic lab work, or mental health referral is appropriate for your situation. Clarify the goals of any recommended therapy and the evidence supporting it.